Insider Buying: GE HealthCare Technologies (NASDAQ:GEHC) Insider Acquires 1,750 Shares of Stock

Key Points

• Insider purchase: GE HealthCare insider Frank Jimenez bought 1,750 shares on April 30 at $60.45 each (total $105,787.50), raising his stake to 93,932 shares — a 1.90% increase in ownership.
• Earnings and guidance hit: Q1 revenue beat at $5.13B but EPS missed ($0.99 vs. ~$1.07 estimate) and management trimmed FY‑2026 EPS guidance to $4.80–$5.00, a move that triggered a steep share selloff amid margin and cost concerns.
• Market stance and payout: Analysts are mixed with a consensus "Hold" and $80.67 target, the stock traded on heavy volume, and the company pays a small quarterly dividend of $0.035 (≈0.2% yield).

GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report) insider Frank Jimenez bought 1,750 shares of the company's stock in a transaction that occurred on Thursday, April 30th. The shares were bought at an average cost of $60.45 per share, for a total transaction of $105,787.50. Following the completion of the acquisition, the insider owned 93,932 shares of the company's stock, valued at $5,678,189.40. This trade represents a 1.90% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock traded up $1.35 during midday trading on Thursday, hitting $60.84. 10,025,557 shares of the company were exchanged, compared to its average volume of 3,890,753. The firm has a market capitalization of $27.76 billion, a PE ratio of 13.34, a price-to-earnings-growth ratio of 1.55 and a beta of 1.17. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The business has a fifty day simple moving average of $73.72 and a two-hundred day simple moving average of $77.64. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.03 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm's revenue was up 7.4% on a year-over-year basis. During the same period last year, the business earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 5 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.07%.

Hedge Funds Weigh In On GE HealthCare Technologies

Hedge funds and other institutional investors have recently made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. lifted its position in shares of GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company's stock valued at $26,000 after acquiring an additional 196 shares in the last quarter. Godsey & Gibb Inc. purchased a new position in shares of GE HealthCare Technologies in the third quarter valued at approximately $26,000. Laurel Wealth Advisors LLC purchased a new position in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $26,000. Optima Capital LLC purchased a new position in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Finally, Godfrey Financial Associates Inc. acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Hedge funds and other institutional investors own 82.06% of the company's stock.

Key Headlines Impacting GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Some investors and commentators argue the pullback is a buying opportunity given compressed valuation and the stock trading well below consensus targets. GE HealthCare Just Crashed 13% on a Guidance Cut. Here's the Case for Buying the Dip
• Positive Sentiment: BTIG continues to rate GEHC a "buy" after trimming its target to $80, signaling further upside from current levels for investors who focus on longer‑term recovery. BTIG Research PT Cut
• Positive Sentiment: Wells Fargo kept an overweight stance even while lowering its target to $75, showing some analysts still see meaningful upside despite near‑term headwinds. Wells Fargo PT Cut
• Neutral Sentiment: Management announced an operational reorganization (combining Imaging and AVS into Advanced Imaging Solutions) and executive changes aimed at improving execution — a structural move that could help margins over time but is not an immediate fix. GE HealthCare operational updates press release
• Neutral Sentiment: Top‑line: Q1 revenue beat estimates ($5.13B vs. ~$5.03B), showing demand resilience in Imaging, AVS and Pharma Diagnostics — positive for growth outlook but offset by margin pressure. GE HealthCare Q1 press release & slide deck
• Negative Sentiment: Profitability: Q1 EPS missed (reported $0.99 vs. ~$1.07 expected) and management trimmed FY26 EPS guidance to $4.80–$5.00 (below consensus). Those misses and the guidance cut triggered the recent steep decline and remain the main reason for investor caution. Reuters: GE HealthCare cuts annual profit forecast
• Negative Sentiment: Cost headwinds: Management cited inflation, higher chip/oil/freight costs, tariffs and supplier issues that pressured margins — analysts and articles highlight execution and inflation risk as key near‑term negatives. WSJ: GE HealthCare cuts outlook as chip, oil prices surge
• Negative Sentiment: Some sell‑side moves trimmed targets and ratings (Citigroup cut its target to $65 and moved to neutral), reflecting reduced near‑term conviction and adding pressure to sentiment. Citigroup PT cut
• Negative Sentiment: Analyst/market writeups emphasize execution risk after Q1 and the guidance cut, suggesting sustained volatility until margin recovery or clearer evidence of execution improvement. Seeking Alpha: Inflation and execution risks weigh on outlook

Wall Street Analyst Weigh In

A number of brokerages have issued reports on GEHC. Morgan Stanley increased their price target on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an "equal weight" rating in a research report on Wednesday, February 4th. The Goldman Sachs Group downgraded GE HealthCare Technologies from a "buy" rating to a "neutral" rating and lowered their price target for the stock from $81.00 to $65.00 in a research report on Thursday. Citigroup lowered their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a "neutral" rating on the stock in a research report on Thursday. Oppenheimer reiterated an "outperform" rating and set a $85.00 price target on shares of GE HealthCare Technologies in a research report on Thursday. Finally, Barclays decreased their target price on GE HealthCare Technologies from $87.00 to $78.00 and set an "equal weight" rating on the stock in a research report on Thursday. Eight analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $80.67.

About GE HealthCare Technologies

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.